Calidi Biotherapeutics, Inc. announced the termination of Chief Legal Officer Wendy Pizarro Campbell’s employment effective October 17, 2025, as part of a cost-reduction initiative; she will receive a severance of $212,500 and a bonus of $85,000 contingent on corporate transactions by October 31, 2025.